More than just bugs in spit

A metabolic biosignature of early response to anti-tuberculosis treatment

(2014) Sebabrata Mahapatra et al.   BMC INFECTIOUS DISEASES

Chemoenzymatic Synthesis of Trehalose Analogues: Rapid Access to Chemical Probes for Investigating Mycobacteria

(2014) Bailey L. Urbanek et al.   CHEMBIOCHEM

The path of anti-tuberculosis drugs: from blood to lesions to mycobacterial cells

(2014) Véronique Dartois   NATURE REVIEWS MICROBIOLOGY

A Four-Month Gatifloxacin-Containing Regimen for Treating Tuberculosis

(2014) Corinne S. Merle et al.   NEW ENGLAND JOURNAL OF MEDICINE

Four-Month Moxifloxacin-Based Regimens for Drug-Sensitive Tuberculosis

(2014) Stephen H. Gillespie et al.   NEW ENGLAND JOURNAL OF MEDICINE

High-Dose Rifapentine with Moxifloxacin for Pulmonary Tuberculosis

(2014) Amina Jindani et al.   NEW ENGLAND JOURNAL OF MEDICINE

PET/CT imaging reveals a therapeutic response to oxazolidinones in macaques and humans with tuberculosis

(2014) M. T. Coleman et al.   Science Translational Medicine

PET/CT imaging correlates with treatment outcome in patients with multidrug-resistant tuberculosis

(2014) R. Y. Chen et al.   Science Translational Medicine

Pharmacokinetic Evaluation of the Penetration of Antituberculosis Agents in Rabbit Pulmonary Lesions

(2011) Maria C. Kjellsson et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Uptake of unnatural trehalose analogs as a reporter for Mycobacterium tuberculosis

(2011) Keriann M Backus et al.   Nature Chemical Biology